Max Robotics — Global Service Robot Directory + US Certification

About

William D. Foulkes is a preeminent cancer geneticist whose research has fundamentally shaped our understanding of hereditary cancer predisposition, with a particular focus on prostate and breast cancer. His pioneering work has explored the genetic architecture underlying cancer risk, asking critical questions about the existence and clinical utility of high-risk genes. His landmark 2000 paper on prostate cancer susceptibility genes, which has garnered 25 citations, laid essential groundwork for understanding how inherited mutations contribute to cancer development. More recently, Foulkes has translated genetic discoveries into actionable clinical frameworks, as demonstrated by his 2024 publication on risk-reducing mastectomy counseling for carriers of BRCA1/2 and PALB2 mutations. This work provides crucial guidance for quantifying residual lifetime risk and absolute surgical benefit, directly impacting patient care. His contributions bridge the gap between molecular genetics and clinical practice, empowering patients and clinicians to make informed decisions about cancer prevention. Through his research, Foulkes has advanced the field of cancer genetics from basic discovery to personalized risk management, establishing himself as a leading voice in hereditary cancer syndromes.